Nordson MEDICAL Divests Contract Manufacturing, Refocuses on Proprietary Components
September 3, 2025 | BUSINESS WIREEstimated reading time: Less than a minute
Nordson Corporation has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical.
“This divestiture allows Nordson MEDICAL to focus on its higher value growth opportunities within our $800 million medical and fluid solutions segment. This includes our growing portfolio of proprietary medical components, including balloons, cannula, nitinol devices and the recently acquired Atrion products,” said Justin Hall, executive vice president, Nordson Medical and Fluid Solutions segment. “We are confident that our contract medical design and development business will thrive under Quasar’s leadership, and we expect a smooth transition for our customers.”
Testimonial
"Our marketing partnership with I-Connect007 is already delivering. Just a day after our press release went live, we received a direct inquiry about our updated products!"
Rachael Temple - AlltematedSuggested Items
Global Wearable Medical Devices Market Predicted to Reach $185 Billion by 2032
10/01/2025 | Globe NewswireThe global wearable medical devices market is expected to increase from USD 43 billion in 2024 to USD 185 billion by 2032, reflecting strong and sustained growth.
NEOTech Celebrates Sixth Mexico Technology Award Win for Outstanding EMS Services Over $100M
09/19/2025 | NEOTechNEOTech, a leading provider of electronic manufacturing services (EMS), design engineering, and supply chain solutions in the high-tech industrial, medical device, and aerospace/defense markets, is proud to announce that it has once again earned the prestigious Mexico Technology Award in the category of EMS Services > $100 Million.
Medical Device OEM/ODM/CDMO Industry Forecast: CAGR of 7.5% to 2031 Amid Growing Healthcare Innovation
09/17/2025 | PRNewswireThe global market for Medical Device OEM/ODM/CDMO was valued at US$ 115434 million in the year 2024 and is projected to reach a revised size of US$ 191760 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
09/15/2025 | GlobeNewswireArmstrong Asia, a leading Singapore-based manufacturer of flexible material solutions with 16 factories across 7 countries in Asia, has signed a Memorandum of Understanding (MOU) with Checkmate Capital Group, LLC (“Checkmate Capital”), a U.S.-based investment and advisory firm active in the Asia-Pacific and North American regions, focused on cross-border transactions in the life sciences, medical technology, and other industries.
Medical Device Contract Manufacturing Market Worth $140.84 Billion by 2030 with 10.9% CAGR
08/25/2025 | PRNewswireThe global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.